Triazol-1-yl Linking Groups for Bacterial Infection Imaging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing bacterial infections are inadequate as they cannot accurately image small numbers of bacteria in vivo, leading to late-stage detection and treatment challenges due to the inability to distinguish infections from other pathologies like cancer and inflammation.
Innovation Solution
The use of 3-iodopropyl-1,2,3-triazol-1-yl and 3-bromopropyl-1,2,3-triazol-1-yl linking groups to generate labeled polysaccharide conjugates for radiolabeling, specifically with fluorine-18, to create imaging agents that can detect bacterial infections through positron emission tomography (PET).
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional contrast agents are used to image bacteria, then imaging capability is provided, but the ability to detect small numbers of bacteria in vivo is insufficient
Solution Approach 1:
The patent applies local quality by designing contrast agents with specific local properties: the polysaccharide component (maltose, maltodextrin) provides bacterial targeting specificity, while the radionuclide component provides detectable signal. This localized functional differentiation enables the agent to both target and detect small numbers of bacteria with high sensitivity, resolving the contradiction between detection sensitivity and bacterial burden quantity.
Solution Approach 2:
The patent employs parameter changes by incorporating radionuclides with different half-lives and emission characteristics (e.g., fluorine-18, iodine-123, iodine-131) to optimize detection sensitivity for different clinical scenarios. The radionuclide selection allows tuning of the imaging parameters to detect varying bacterial burdens, thereby improving measurement precision across different quantity ranges.
2Measurement precision
If conventional contrast agents are used, then imaging is possible, but the ability to distinguish infections from other pathologies is insufficient
Solution Approach 1:
The patent applies segmentation by separating the diagnostic function into distinct components: the polysaccharide moiety provides infection-specific targeting, while the radionuclide provides the imaging signal. This functional segmentation allows the imaging system to specifically visualize bacterial infections without requiring complex multi-modal imaging, thereby improving diagnostic accuracy while maintaining relative system simplicity.
Solution Approach 2:
The patent uses the polysaccharide-radionuclide conjugate as an intermediary that specifically binds to bacterial components (cell wall, glycocalyx). This intermediary selectively accumulates at infection sites, enabling the imaging system to distinguish infections from other pathologies like cancer and inflammation through specific bacterial targeting, improving diagnostic accuracy without increasing system complexity.
3Measurement precision
If blood cultures or tissue biopsy are used for diagnosis, then detection is possible, but only late-stage infections can be detected
Solution Approach 1:
The patent applies preliminary action by enabling non-invasive imaging detection that can identify infections at early stages before they become systematic or cause significant tissue damage. The radionuclide-labeled polysaccharide agents can detect small bacterial burdens in vivo, allowing diagnosis and treatment initiation before the infection progresses to late stages, thereby reducing the loss of time in diagnosis.
4Reliability
If radionuclide labeling is performed, then imaging agents are generated, but radiochemical yield stability and reproducibility must be maintained
Solution Approach 1:
The patent uses the triazole linking group as an intermediary that provides stable covalent bonding between the polysaccharide and radionuclide. This stable linkage ensures reliable radiochemical yields and reproducible labeling, resolving the contradiction between reliability and ease of manufacture by creating a robust conjugate structure that maintains stability throughout the manufacturing and imaging processes.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These agents provide stable and reproducible radiochemical yields, enabling the accurate detection of bacterial infections at early stages, improving treatment outcomes by visualizing small bacterial burdens within the body.
Implementation Method 1
using 3-iodopropyl-1,2,3-triazol-1-yl, 3-bromopropyl-1,2,3-triazol-1-yl, and derivatives as linking groups for generating labeled conjugates... specifically with fluorine-18, to create imaging agents that can detect bacterial infections through positron emission tomography (PET)
Data Source
AI summary
This disclosure relates to using 3-iodopropyl-1,2,3-triazol-1-yl or 3-bromopropyl-1,2,3-triazol-1-yl as linking groups for generating labeled conjugates. In certain embodiments, disclosure relates to using 3-iodopropyl-1,2,3-triazol-1-yl or 3-bromo-propyl-1,2,3-triazol-1-yl as linking groups for generating labeled polysaccharide conjugates or derivatives. In certain embodiments, this disclosure relates to methods of generating radionuclides.